As we monitor the spread of the omicron subvariant BA.2 in the US, the number of people in hospital with covid-19 has dropped to below 30 0002 and daily cases are continuing to decline.3 Still, our more than 969 000 deaths3 from covid-19 in the US should make us all pause and ...
Death rates were much higher than Covid-19, ranging from 43 percent in the kingdom to around 50 percent in the capital [23]. The epidemic had really put the authorities to the test, forcing them to take sometimes stringent measures which in most cases proved ineffective. In fact, in the...
As the use of this platform has increased with the rollout of the ChAdOx COVID-19 vaccine and potential future use of the vector, particularly for viruses and other pathogens endemic to the same areas i.e. Ebola, LASV and Malaria, vector-specific immunity and its potential role in vaccine...
A person has been charged with dangerous driving causing death after a woman died on a Vancouver road. After a nine-month-long investigation by Vancouver police, a person has been arrested and charged. Sina Mogharei, 32, has been charged with dangerous driving causing death and failure to sto...
Meanwhile, the crude death rate of COVID-19 was 2.3% and the death rate was 0.015/10 person-days [34], much lower than the mortality rates of SARS [44]. Severe illness and death are more common in older patients with underlying condi- tions. Meanwhile, SARS-CoV-2 not only affects ...
covid_world_total_cases value_template: '{{ states.sensor.covid_world.attributes["Total_Cases"] | replace(",","")| int | round(0) }}' unit_of_measurement: '#' - name: covid_world_total_recovered value_template: '{{ states.sensor.covid_world.attributes["Total_Recovered"] | replac...
Although the clinical spectrum of COVID-19 is heterogeneous, patients with active malignancy experience more severe disease and higher observed death rates from COVID-19, which have ranged between 5% and 61%, with a recent meta-analysis-based estimate of 25.6% (Dai et al., 2020; Giannakoulis...
patients with severe and critical COVID-19 infections were at substantially higher risk of developing acute kidney injury with varying outcomes of sustained kidney injury, recovery, need for renal replacement therapy, or death. Predictor factors for severe acute kidney injury overlapped between the diff...
Coronavirus COVID-19 SARS-CoV-2 N protein Antagonists Inhibitors 1. Introduction Human coronaviruses (HCoVs), including HCoV-229E, HCoV-NL63, HCoV-OC43 and HCoV-HKU1 typically cause subclinical infections [1]. However, three novel coronaviruses (CoVs) with high mortality rates have emerged ...
Effect of sotrovimab on hospitalization or death among high-risk patients with mild to moderate COVID-19: A randomized clinical trial JAMA, 327 (2022), pp. 1236-1246 10.1001/jama.2022.2832 35285853 CrossrefView in ScopusGoogle Scholar 11. Q Hu, Y Xiong, GH Zhu, YN Zhang, YW Zhang, P...